Southern JA - Search Results

1

Sequence comparison between the haemagglutinin-neuraminidase genes of simian, canine and human isolates of simian virus 5.

Baty DU, Southern JA, Randall RE. Baty DU, et al. Among authors: southern ja. J Gen Virol. 1991 Dec;72 ( Pt 12):3103-7. doi: 10.1099/0022-1317-72-12-3103. J Gen Virol. 1991. PMID: 1765772

2

Identification of an epitope on the P and V proteins of simian virus 5 that distinguishes between two isolates with different biological characteristics.

Southern JA, Young DF, Heaney F, Baumgärtner WK, Randall RE. Southern JA, et al. J Gen Virol. 1991 Jul;72 ( Pt 7):1551-7. doi: 10.1099/0022-1317-72-7-1551. J Gen Virol. 1991. PMID: 1713260

3

Sequence analysis of the HN gene of parainfluenza virus type 2.

Precious B, Southern JA, Randall RE. Precious B, et al. Among authors: southern ja. J Gen Virol. 1990 May;71 ( Pt 5):1163-8. doi: 10.1099/0022-1317-71-5-1163. J Gen Virol. 1990. PMID: 2161050

4

Two nontemplated nucleotide additions are required to generate the P mRNA of parainfluenza virus type 2 since the RNA genome encodes protein V.

Southern JA, Precious B, Randall RE. Southern JA, et al. Virology. 1990 Jul;177(1):388-90. doi: 10.1016/0042-6822(90)90497-f. Virology. 1990. PMID: 2162111

5

Immunization with solid matrix-antibody-antigen complexes containing surface or internal virus structural proteins protects mice from infection with the paramyxovirus, simian virus 5.

Randall RE, Young DF, Southern JA. Randall RE, et al. Among authors: southern ja. J Gen Virol. 1988 Oct;69 ( Pt 10):2517-26. doi: 10.1099/0022-1317-69-10-2517. J Gen Virol. 1988. PMID: 3171549

6

Two-tag purification of recombinant proteins for the construction of solid matrix-antibody-antigen (SMAA) complexes as vaccines.

Randall RE, Hanke T, Young D, Southern JA. Randall RE, et al. Among authors: southern ja. Vaccine. 1993 Sep;11(12):1247-52. doi: 10.1016/0264-410x(93)90050-8. Vaccine. 1993. PMID: 7504859

7

Use of traditional serological methods and oral fluids to assess immunogenicity in children aged 2-16 years after successive annual vaccinations with LAIV.

Hoschler K, Maharjan S, Whitaker H, Southern J, Okai B, Baldevarona J, Turner PJ, Andrews NJ, Miller E, Zambon M. Hoschler K, et al. Vaccine. 2020 Mar 10;38(12):2660-2670. doi: 10.1016/j.vaccine.2020.02.024. Epub 2020 Feb 15. Vaccine. 2020. PMID: 32070679 Free PMC article. Clinical Trial.

8

Responses to live attenuated influenza vaccine in children vaccinated previously with Pandemrix (ASO3_B adjuvanted pandemic A/H1N1pdm09).

Höschler K, Southern J, Thompson C, Warburton F, Andrews NJ, Miller E, Zambon M. Höschler K, et al. Vaccine. 2018 May 17;36(21):3034-3040. doi: 10.1016/j.vaccine.2018.04.017. Epub 2018 Apr 19. Vaccine. 2018. PMID: 29680198 Clinical Trial.

9

Binding antibody levels to vaccine (HPV6/11/16/18) and non-vaccine (HPV31/33/45/52/58) HPV antigens up to 7 years following immunization with either Cervarix® or Gardasil® vaccine.

Panwar K, Godi A, Cocuzza CE, Andrews N, Southern J, Turner P, Miller E, Beddows S. Panwar K, et al. Vaccine. 2022 Feb 23;40(9):1198-1202. doi: 10.1016/j.vaccine.2022.01.041. Epub 2022 Feb 1. Vaccine. 2022. PMID: 35115194 Free article.

10

Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers.

Southern J, Andrews N, Burrage M, Miller E. Southern J, et al. Vaccine. 2005 May 31;23(29):3829-35. doi: 10.1016/j.vaccine.2005.02.030. Epub 2005 Mar 30. Vaccine. 2005. PMID: 15893621 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters